Last reviewed · How we verify
NCT04359030
Freestyle-Perimount Calcification Comparison
trial testing Multislice CT scanning for aortic wall calcification in Aortic Valve Disease in 90 participants. Completed in 1 October 2022.
1 June 2022
Quick facts
| Lead sponsor | Ziekenhuis Oost-Limburg |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 90 |
| Start date | 15 November 2021 |
| Primary completion | 1 June 2022 |
| Estimated completion | 1 October 2022 |
| Sites | 1 location across Belgium |
Drugs / interventions tested
- Multislice CT scanning for aortic wall calcification
- Transthoracic stress echocardiography
Conditions studied
- Aortic Valve Disease — all drugs for Aortic Valve Disease →
- Valve Heart Disease — all drugs for Valve Heart Disease →
Sponsor
Ziekenhuis Oost-Limburg — full company profile →
Who can join
Under 60, any sex, with Aortic Valve Disease or Valve Heart Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to evaluate the rate and anatomy of the aortic wall and leaflet calcification of the FS prosthesis implanted as full root in patients younger than 60 years compared to a stented bioprostheses (Perimount Magna Ease, PM). A 3D CT scan will be used to assess the calcification score and to determine the relationship between calcification and aortic valve leaflet.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04359030
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aortic Valve Disease
Currently open trials in the same condition.
- NCT07008911 — CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation · NA · recruiting
- NCT07267117 — Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease · recruiting
- NCT07021612 — A Clinical and Imaging Registry of Transcatheter Aortic Valve Implantation Using JenaValve System/ J-Valve System for Pa · recruiting
- NCT06896227 — TAVR: The Impact of Prothesis Positioning on Valvular and Coronary Hemodynamics · NA · recruiting
- NCT06189976 — Rapid Atrial Pacing After TAVI to Predict Pacemaker Implantation · NA · recruiting
Other Ziekenhuis Oost-Limburg trials
Trials by the same sponsor.
- NCT07281534 — Test-Retest Reliability of Cardiopulmonary Exercise Testing With Echocardiography · NA · recruiting
- NCT07123818 — AI for Detection of Brain Aneurysm: Low-cost Opportunistic Screening · NA · active not recruiting
- NCT06994091 — Imaging Comparison for the Preoperative Planning and Diagnosis of DIE: a Multicenter Retrospective Study. · not yet recruiting
- NCT06185608 — The Effects of Various Concentrations of Ropivacaine on the Onset and Duration of Ankle Blocks · NA · recruiting
- NCT06810479 — A Study Comparing Two Mandibular Advancement Devices in the Treatment of Sleep Apnea · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04359030 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ziekenhuis Oost-Limburg
- Last refreshed: 24 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04359030.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing